| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 16210* | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 631 | 2020 |
| Nanoparticles and targeted drug delivery in cancer therapy B Bahrami, M Hojjat-Farsangi, H Mohammadi, E Anvari, G Ghalamfarsa, ... Immunology letters 190, 64-83, 2017 | 581 | 2017 |
| Th17 cell, the new player of neuroinflammatory process in multiple sclerosis F Jadidi‐Niaragh, A Mirshafiey Scandinavian journal of immunology 74 (1), 1-13, 2011 | 557 | 2011 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 552 | 2024 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 530 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 484 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
| The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer A Masjedi, V Hashemi, M Hojjat-Farsangi, G Ghalamfarsa, G Azizi, ... Biomedicine & Pharmacotherapy 108, 1415-1424, 2018 | 296 | 2018 |
| The paradox of Th17 cell functions in tumor immunity Z Asadzadeh, H Mohammadi, E Safarzadeh, M Hemmatzadeh, ... Cellular immunology 322, 15-25, 2017 | 228 | 2017 |
| A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders AN Kamali, SM Noorbakhsh, H Hamedifar, F Jadidi-Niaragh, R Yazdani, ... Molecular immunology 105, 107-115, 2019 | 204 | 2019 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 180 | 2022 |
| Utilization of nanoparticle technology in rheumatoid arthritis treatment S Dolati, S Sadreddini, D Rostamzadeh, M Ahmadi, F Jadidi-Niaragh, ... Biomedicine & pharmacotherapy 80, 30-41, 2016 | 178 | 2016 |
| Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls A Sadeghi, S Tahmasebi, A Mahmood, M Kuznetsova, H Valizadeh, ... Journal of cellular physiology 236 (4), 2829-2839, 2021 | 174 | 2021 |
| CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice F Jadidi-Niaragh, F Atyabi, A Rastegari, N Kheshtchin, S Arab, ... Journal of Controlled Release 246, 46-59, 2017 | 171 | 2017 |
| Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis G Azizi, F Jadidi‐Niaragh, A Mirshafiey International journal of rheumatic diseases 16 (3), 243-253, 2013 | 171 | 2013 |
| Immune regulatory network in successful pregnancy and reproductive failures M Ghaebi, M Nouri, A Ghasemzadeh, L Farzadi, F Jadidi-Niaragh, ... Biomedicine & Pharmacotherapy 88, 61-73, 2017 | 167 | 2017 |
| Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review M Jamee, S Moniri, M Zaki-Dizaji, P Olbrich, R Yazdani, F Jadidi-Niaragh, ... Clinical reviews in allergy & immunology 59, 323-333, 2020 | 155 | 2020 |